Multithread effectively and personalize outreach to convert deals faster
Elevate social presence and drive business growth from social media
Identify and prioritize high-intent leads, and improve sales effectiveness
Find and connect with ICP attendees, and improve event outcomes
Visikol is a Contract Research Organization (CRO) dedicated to advancing drug discovery and development through cutting-edge imaging and analysis services. They specialize in 3D tissue imaging, utilizing proprietary Visikol® HISTO-M® tissue clearing technology, 3D cell culture assays, high content screening, digital pathology with AI-driven image analysis, and multiplex imaging. By providing detailed insights into drug efficacy, mode of action, and disease pathology, Visikol empowers pharmaceutical companies, biotech firms, and academic researchers to make more informed decisions, accelerate their research pipelines, and ultimately bring new therapies to patients faster. Visikol is part of the BICO group.
Primary research and development, laboratory services, client project management, and administrative operations.
State-of-the-art laboratory facilities equipped for advanced imaging, 3D cell culture, and digital pathology services. Located within University Research Park, fostering collaboration and innovation.
Collaborative, science-driven environment focused on innovation and delivering high-quality data for clients. Emphasis on teamwork, continuous learning, and problem-solving in the field of drug discovery.
Serves as the central hub for Visikol's cutting-edge research services, strategic operations, and client engagement. Proximity to a major research university and biotech ecosystem in Madison enhances talent acquisition and collaborative opportunities.
Visikol serves a global clientele, including pharmaceutical companies, biotechnology firms, and academic research institutions across North America, Europe, and Asia. Their services support drug discovery and development programs worldwide. As part of the BICO Group, Visikol leverages a broader global network and infrastructure, enhancing its ability to support international projects and collaborations.
505 S. Rosa Rd. Suite 230
Madison
WI
USA
Address: 395 Route 31 North, Hampton, NJ 08827, USA
Provides specialized bioimaging services and supports client projects, leveraging its proximity to the dense concentration of life science companies in New Jersey and the surrounding East Coast region.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Visikol' leadership includes:
Visikol has been backed by several prominent investors over the years, including:
No major C-suite executive hires or departures specific to Visikol's direct leadership team have been prominently announced in the public domain within the last 12 months. Visikol continues its operations and growth under its established leadership as part of the BICO group.
Discover the tools Visikol uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Visikol primarily uses the [first].[last]@visikol.com email format for its employees. This is a common and professional structure for company communications.
[first].[last]@visikol.com
Format
michael.johnson@visikol.com
Example
95%
Success rate
Business Wire • May 8, 2024
Visikol announced a strategic partnership with Nortis Bio to enhance its organ-on-a-chip (OOC) service offerings. This collaboration integrates Nortis' ParVivo™ platform, enabling advanced microfluidic 3D cell culture models for improved drug efficacy and toxicity screening....more
Business Wire • February 27, 2024
Visikol expanded its advanced in vitro services to include organotypic slice cultures. This addition allows for ex vivo studies that better mimic in vivo tissue environments, providing more relevant data for drug discovery and preclinical research....more
Business Wire • October 11, 2023
Visikol partnered with MIMETAS to provide advanced, human-relevant drug efficacy testing services. The collaboration combines Visikol's expertise in high-content imaging and analysis with MIMETAS' OrganoPlate® platform for developing and testing compounds in 3D human tissue models....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Visikol, are just a search away.